Healthcare / Pharma Commercial

    Pharma commercial launch software

    A launch puts samples, promotional pieces and speaker programs in the field at the same time, and each one leaves a record a regulator can ask for. Agnotic Technologies builds the commercial systems a drug maker needs to launch within the rules, connected to the CRM and data platforms it already runs.

    Samples
    Requested, signed, delivered and reconciled
    Promotion
    Approved version and first use on record
    Payments
    Transfers of value captured at the source

    Trusted by global innovators

    Benchmark
    Chibasco
    Fundency
    Lantimer
    Lauren
    Lera
    One Minute
    Pento Pix
    TAP
    Xtrium
    Healthevolve
    Benchmark
    Chibasco
    Fundency
    Lantimer
    Lauren
    Lera
    One Minute
    Pento Pix
    TAP
    Xtrium
    Healthevolve
    Benchmark
    Chibasco
    Fundency
    Lantimer
    Lauren
    Lera
    One Minute
    Pento Pix
    TAP
    Xtrium
    Healthevolve
    Benchmark
    Chibasco
    Fundency
    Lantimer
    Lauren
    Lera
    One Minute
    Pento Pix
    TAP
    Xtrium
    Healthevolve
    Industry Overview

    What is pharma commercial launch software?

    Pharma commercial launch software is the set of systems a drug maker's commercial team needs to launch within the rules: HCP master data and engagement records, sample requests and accountability under PDMA, promotional review with Form FDA 2253 tracking, and transfers of value data for Open Payments. Agnotic Technologies builds and connects these systems for pharmaceutical companies.

    Industry Challenges

    Where do launch teams lose control of commercial records?

    Each of these turns into a scramble before an audit or a reporting deadline.

    • Sample requests are signed on paper or in one app, and the signature cannot be linked to the delivery record.

    • The annual sample inventory does not reconcile with the last one, and nobody can show why.

    • The piece a representative shows is not the version that was approved.

    • Nobody knows the date a piece was first used, so the Form FDA 2253 submission is late or missing.

    • Speaker program meals and fees are rebuilt from expense reports when the Open Payments report is due.

    • The same physician appears three times across CRM, sampling and events, with different licence numbers.

    • Withdrawn or expired material stays on representatives' tablets.

    Our Approach

    How should a commercial team approach the build?

    Three choices that make every report a query instead of a project.

    One HCP master

    One record per prescriber, with identifiers such as NPI and State licence numbers, used by CRM, sampling, events and payments alike.

    Link every piece to its approval and first use

    Each promotional piece carries its approved version, expiry date and the date it was first disseminated, so the 2253 package can be prepared on time.

    Capture transfers of value at the source

    Meals, fees and travel are recorded against the HCP master when they happen, not reconstructed from expenses at year end.

    Capabilities

    What do we build for pharma commercial teams?

    Systems we build, extend or connect around your existing commercial stack.

    HCP master data hub

    Matching and survivorship rules across CRM, sampling, events and third-party reference data.

    Engagement records

    Calls, events and materials used, tied to the HCP and the approved piece.

    Sample request and signature capture

    Written requests with the fields PDMA requires, captured before delivery.

    Sample inventory and reconciliation

    Representative inventories, transfers and the annual physical count reconciled with the last one.

    Promotional review workflow

    Medical, legal and regulatory review with versions, comments and approvals on record.

    Form FDA 2253 tracking

    First-use dates captured and the submission package prepared for your regulatory team.

    Transfers of value capture

    Payments and other transfers recorded against the HCP master for annual reporting.

    Commercial reporting

    Launch dashboards for sampling, content in use and HCP data quality.

    How It Works

    How does a promotional piece move from draft to the field?

    The workflow we build for each piece, with every step recorded.

    Draft with references

    Claims linked to the references that support them.

    1

    Medical, legal and regulatory review

    Each reviewer comments on a version, and every version is kept.

    2

    Approve the final version

    Approval, approvers and an expiry or review date recorded.

    3

    Prepare the 2253 package

    At first dissemination, the piece and the current professional labeling are packaged for your regulatory team to submit.

    4

    Release to field channels

    Only the approved version reaches representative tablets, email templates and the web.

    5

    Track use

    Which representatives showed which piece to which HCP, and when.

    6

    Withdraw

    Expired or withdrawn pieces are pulled from every channel at once.

    7
    Engineering Stack

    Which systems does commercial software connect?

    We work with the platforms you license and fill the gaps between them.

    Engagement

    CRMRepresentative tablet appsEvent management

    Content

    Digital asset managementReview and approval toolsApproved email templates

    Data

    HCP reference data with NPI and State licence numbersCommercial data warehouse

    Platform

    Role-based accessAudit trailEncryption in transit and at restAWS or Azure in your account
    Measured Impact

    What should a launch team see each week?

    Measures we build into the launch dashboard.

    Samples
    Accountability

    Requests with signatures, deliveries and open discrepancies.

    Content
    Approved in use

    Pieces in the field on their approved version, and any past expiry.

    Payments
    Capture at source

    Transfers of value recorded when they happened, not at year end.

    HCP data
    Master quality

    Duplicates, missing identifiers and lapsed licences.

    My Lauren Maternal Health Platform | Built by Agnotic

    A HIPAA-ready maternal health platform enabling remote patient monitoring, care coordination, and personalized engagement from pre-pregnancy through postpartum.

    Case Study
    My Lauren Maternal Health Platform | Built by Agnotic
    LERA Health: Women's Health App Platform

    LERA Health: Women's Health App Platform

    A women’s health product experience focused on guided care journeys, education, and compliance-aware workflows to support long-term engagement.

    Case Study
    Use Cases

    Which commercial teams build with us?

    Teams that need regulated workflows, not another sales tool.

    01

    Emerging biopharma at first launch

    Sampling, promotional review and payments set up before the field team starts.

    02

    Specialty pharma

    Smaller field teams with complex speaker programs.

    03

    Commercial operations

    Reporting that comes from records instead of spreadsheets.

    04

    Compliance teams

    Evidence for sampling, promotion and payments in one place.

    05

    Medical affairs

    Clear separation between medical and promotional engagement records.

    06

    Companies changing CRM

    Commercial records moved without losing the audit trail.

    Integrations

    Which systems does the build connect to?

    The systems around the HCP master.

    Engagement

    CRM

    Shipments and receipts

    Sample fulfilment providers

    Approvals

    Content review system

    Transfers of value

    Expense and event tools

    HCP identifiers

    Reference data providers

    Reporting

    Commercial data warehouse
    What we check

    Which records must be in place before launch?

    Our launch readiness checklist: each regulated commercial activity, the record the software must hold and the rule behind it. Your compliance and regulatory teams own the policies; the software holds the evidence.

    Sampling

    • Written request signed by the licensed practitioner before delivery (21 CFR 203.31(a)(1))
    • Practitioner name, address, title, State licence number, drug, strength and quantity on each request (21 CFR 203.31(b))
    • Delivery confirmation linked to the request
    • Annual physical inventory per representative, reconciled with the prior inventory (21 CFR 203.31(d))

    Promotional materials

    • Approved version of each piece, with reviewers and approval date
    • First dissemination date and the Form FDA-2253 package with current professional labeling (21 CFR 314.81(b)(3)(i))
    • Expiry and withdrawal dates applied across every channel

    Speaker programs and HCP payments

    • Each payment or transfer of value recorded against the HCP master with date, amount and nature
    • Annual data set for the preceding calendar year (42 CFR 403.904(a)(1))
    • Review and correction trail for disputed records

    HCP data

    • One master record per HCP with identifiers and licence status
    • Contact preferences and consent where they apply
    • Licence checks before a sample request is accepted

    Compliance-First Development Services Backed by Global Standards

    We build secure, scalable products designed for privacy, interoperability, and regulatory readiness from day one across every sector we serve.

    GDPR logo

    General Data Protection Regulation

    Implement lawful consent flows, data minimization, and secure processing for global data privacy.

    Our Edge

    Why Global Leaders Choose Us

    We combine deep technical expertise with industry-specific knowledge to deliver solutions that aren't just functional, but transformational.

    Enterprise-Grade Security

    We implement rigorous security protocols and compliance standards (HIPAA, GDPR, SOC2) across all industrial solutions to protect sensitive data.

    High-Performance Scaling

    Our architectures are built to handle massive data loads and user bases, keeping performance steady whether you're serving ten or ten million.

    Accelerated Time-to-Market

    Using our suite of internal tools and proven frameworks, we cut setup work so your first release reaches users sooner.

    Embedded AI Integration

    Beyond simple wrappers, we build deep-learning integrations and predictive analytics directly into the core of your industry-specific workflows.

    Engagement Model

    How does a pharma commercial engagement work?

    We build in launch order. Timing depends on scope; we agree a fixed first release on the scoping call.

    01

    Scoping call

    We review your launch plan, field model and the commercial systems you already license.

    02

    Launch calendar mapping

    Which activities start when, and the records each one needs from day one.

    03

    First release

    The activity that starts first, usually sampling or promotional review, working end to end.

    04

    Payments and reporting

    Transfers of value capture and launch dashboards added on the HCP master.

    05

    Support

    Changes for new indications, products and field teams under change control.

    Facts and sources

    Which rules shape pharma commercial records?

    Short facts we design the sampling, promotion and payment records around, each linked to its primary source.

    • A drug sample delivered by a representative needs a written request signed by the licensed practitioner before delivery, and the request must include the practitioner's name, address, title, State license number, the drug, its strength and the quantity requested.

      Source: 21 CFR 203.31(a)(1) and (b) (eCFR)
    • A manufacturer that distributes drug samples through representatives must conduct a complete physical inventory of all samples at least annually and reconcile the results with the most recent prior inventory.

      Source: 21 CFR 203.31(d) (eCFR)
    • The applicant must submit specimens of promotional labeling and advertising at the time of initial dissemination or publication, each accompanied by a completed Form FDA-2253 and a copy of the product's current professional labeling.

      Source: 21 CFR 314.81(b)(3)(i) (eCFR)
    • Applicable manufacturers must report to CMS each year the direct and indirect payments or other transfers of value they provided to covered recipients during the preceding calendar year.

      Source: 42 CFR 403.904(a)(1) (eCFR)

    Voice of success

    We don't just build products; we forge lasting partnerships. See how we've helped industry leaders transform their vision into technical reality.

    Benchmark

    “I can clearly see how Agnotic has a unique way of handling end-to-end development. They are always active on quick chat and provide support quickly.”

    Aaron Phelan

    Aaron Phelan

    Founder, Benchmark

    Latimer

    “Agnotic combines deep technical expertise with strong domain knowledge. They understand the business context, anticipate challenges, and make collaboration smooth and effective.”

    John Pasmore

    John Pasmore

    Founder, Latimer

    My Lauren

    “Agnotic is the best technical team we evaluated. Their engineering excellence made our work dramatically easier and allowed us to stay focused on what matters most for maternal care outcomes. They took full ownership of the technical execution, and we are always happy to continue working together.”

    Kim Smith

    Kim Smith

    Founder, My Lauren

    Related services

    Related pharma and life sciences software

    This page covers regulated commercial workflows. These pages cover the rest of a drug maker's systems.

    Cross-Industry Reach

    The Same Engineering Patterns, Across Other Industries

    The technical patterns behind this platform translate naturally into adjacent verticals.

    Frequently Asked Questions

    No. Most companies already license a CRM. We build the regulated workflows and records around it, such as sampling, promotional review tracking and transfers of value, and extend the CRM where that is the cleaner option.